Approval · Notice of Compliance 3902 · 1997
XALATAN: Notice of Compliance 3902
Issued June 16, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3902
- Date
- June 16, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Prostaglandin F2-analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XALATAN | 02231493 | Marketed |
Medicinal ingredients
- LATANOPROST 50 MCG per ML